Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Avi Avramoff"'
Publikováno v:
Journal of Controlled Release. 160:401-406
Objective Preparation and characterization of an oral pro-dispersion liposphere formulation for cyclosporin, a water insoluble drug with limited bioavailability. Methods Pro-dispersion formulation consisted of a solid fat, dispersing agents and amphi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c74453f0e5a980ca8060445c83f138
https://doi.org/10.1016/j.jconrel.2011.12.016
https://doi.org/10.1016/j.jconrel.2011.12.016
Publikováno v:
Journal of Applied Polymer Science. 126:E197-E203
The aim of the present study was to develop a once-daily, delayed controlled release formulation for diltiazem. Developed formulation consists of two coated tablets inserted into a capsule; the first tablet is intended to produce a fast release profi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cf03dbc53c4f9e96d15d3e0513c40a2
https://doi.org/10.1002/app.36755
https://doi.org/10.1002/app.36755
Publikováno v:
Journal of Clinical Periodontology
Local delivery of antimicrobial agents as an adjunctive tool in the treatment of periodontal disease has been in use for over three decades now (Lindhe et al. 1979). An array of agents has been tested with varying degree of success. These are general
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c362e3215aa2e623ca95cbc9bbb06fd
http://europepmc.org/articles/PMC3586660
http://europepmc.org/articles/PMC3586660
Autor:
Abraham J. Domb, Avi Avramoff
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 48:250-258
Objective The aim of the present study was to evaluate the in-vitro dissolution and in-vivo pharmacokinetic profile of a novel two-phase modified-release formulation for diltiazem hydrochloride, as a water-soluble drug. Materials and methods The deli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b766f625afacdfae588ecfc6a2d9db35
https://doi.org/10.5414/cpp48250
https://doi.org/10.5414/cpp48250
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 45:126-132
Objective: A study was conducted to establish the bioequivalence between a newly developed cyclosporin A (CsA) oral formulation, Deximune® soft-gelatin capsules (Dexcel Ltd.) and Sandimmune Neoral® (Novartis Inc.). Materials and methods: The clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::634f740dfdddfd730043af854e79b0a1
https://doi.org/10.5414/cpp45126
https://doi.org/10.5414/cpp45126
Publikováno v:
International journal of pharmaceutics. 437(1-2)
Cyclosporin A (CsA) is a widely used anti-inflammatory agent for the management of dry eye disease, and is available commercially as ophthalmic emulsion formulation (RESTASIS(®)). For increasing efficacy, and for reducing local toxicity including ir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a7080b60da72e5aed92925ca3cbd51f
https://pubmed.ncbi.nlm.nih.gov/22951866
https://pubmed.ncbi.nlm.nih.gov/22951866
Publikováno v:
International Journal of Pharmaceutics. 111:197-202
We have recently discovered that peptides are absorbed biologically intact from the rat uterus. The purpose of this investigation was to assess whether EPO, a large polypeptide hormone (34.5 kDa), can be absorbed from the uterus into the systemic blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::810bc44fce525d0c125dc0bbecd446df
https://doi.org/10.1016/0378-5173(94)00144-8
https://doi.org/10.1016/0378-5173(94)00144-8
Publikováno v:
Pharmaceutical Research. 10:828-833
High molecular weight drugs in general, and peptides in particular, are usually delivered by parenteral route because they are poorly absorbed or degraded in the gastrointestinal tract. To optimize therapy, it is desirable to search for nonparenteral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb1804ac6c64f03d6ce260cd550cfc55
https://doi.org/10.1023/a:1018948924992
https://doi.org/10.1023/a:1018948924992
Publikováno v:
International journal of clinical pharmacology and therapeutics. 46(4)
Objective: Deximune® soft-gelatin capsules (Dexcel Ltd., Hadera, Israel), the test preparation and Sandimmun Neoral® (Novartis Inc., Basel, Switzerland), the reference preparation, are two cyclosporine (CyA) formulations widely used after stem cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf396eef6e5315786e75922965f46271
https://pubmed.ncbi.nlm.nih.gov/18397689
https://pubmed.ncbi.nlm.nih.gov/18397689